Literature DB >> 21120723

Moraxella catarrhalis - pathogen or commensal?

Christoph Aebi1.   

Abstract

Moraxella catarrhalis is an exclusively human commensal and mucosal pathogen. Its role as a disease-causing organism has long been questioned. Today, it is recognized as one of the major causes of acute otitis media in children, and its relative frequency of isolation from both the nasopharynx and the middle ear cavity has increased since the introduction of the heptavalent pneumococcal conjugate vaccine, which is associated with a shift in the composition of the nasopharyngeal flora in infants and young children. Although otitis media caused by M. catarrhalis is generally believed to be mild in comparison with pneumococcal disease, numerous putative virulence factors have now been identified and it has been shown that several surface components of M. catarrhalis induce mucosal inflammation. In adults with chronic obstructive pulmonary disease (COPD), M. catarrhalis is now a well-established trigger of approximately 10% of acute inflammatory exacerbations.Although the so-called cold shock response is a well-described bacterial stress response in species such as Escherichia coli, Bacillus subtilis or - more recently - Staphylococcus aureus, M. catarrhalis is the only typical nasopharyngeal pathogen in which this response has been investigated. Indeed, a 3-h 26°C cold shock, which may occur physiologically, when humans inspire cold air for prolonged periods of time, increases epithelial cell adherence and enhances proinflammatory host responses and may thus contribute to the symptoms referred to as common cold, which typically are attributed to viral infections.

Entities:  

Mesh:

Year:  2011        PMID: 21120723     DOI: 10.1007/978-1-4419-7185-2_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  17 in total

1.  Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract.

Authors:  Megan M Jones; Antoinette Johnson; Mary Koszelak-Rosenblum; Charmaine Kirkham; Aimee L Brauer; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Moraxella Species as Potential Sources of MCR-Like Polymyxin Resistance Determinants.

Authors:  Nicolas Kieffer; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

3.  Expression of the Oligopeptide Permease Operon of Moraxella catarrhalis Is Regulated by Temperature and Nutrient Availability.

Authors:  Megan M Jones; Timothy F Murphy
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

Review 4.  Impact of nasopharyngeal microbiota on the development of respiratory tract diseases.

Authors:  S Esposito; N Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-09       Impact factor: 3.267

5.  Respiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis media.

Authors:  M Elizabeth Brockson; Laura A Novotny; Joseph A Jurcisek; Glen McGillivary; Martha R Bowers; Lauren O Bakaletz
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

6.  Alternations in DNA gyrase genes in low-level fluoroquinolone-resistant Moraxella catarrhalis strains isolated in Poland.

Authors:  Katarzyna Król-Turmińska; Alina Olender
Journal:  Infect Drug Resist       Date:  2018-08-06       Impact factor: 4.003

7.  Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?

Authors:  Anna Marchese; Susanna Esposito; Ramona Barbieri; Matteo Bassetti; Eugenio Debbia
Journal:  BMC Infect Dis       Date:  2012-08-06       Impact factor: 3.090

8.  Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections.

Authors:  Safia Bader Uddin Shaikh; Zafar Ahmed; Syed Ali Arsalan; Sana Shafiq
Journal:  Infect Drug Resist       Date:  2015-07-31       Impact factor: 4.003

9.  Pneumococcal Colonization Rates in Patients Admitted to a United Kingdom Hospital with Lower Respiratory Tract Infection: a Prospective Case-Control Study.

Authors:  Andrea M Collins; Catherine M K Johnstone; Jenna F Gritzfeld; Antonia Banyard; Carole A Hancock; Angela D Wright; Laura Macfarlane; Daniela M Ferreira; Stephen B Gordon
Journal:  J Clin Microbiol       Date:  2016-01-20       Impact factor: 5.948

10.  Antibacterial Fusion Proteins Enhance Moraxella catarrhalis Killing.

Authors:  Maisem Laabei; Lucie Colineau; Serena Bettoni; Karolina Maziarz; David Ermert; Kristian Riesbeck; Sanjay Ram; Anna M Blom
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.